- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03181672
Stellate Ganglion Block on Tourniquet Response
June 7, 2017 updated by: The Affiliated Hospital of Xuzhou Medical University
Influence of Stellate Ganglion Block on Tourniquet Response in Lower Limbs.
To investigate the influence of stellate ganglion block on tourniquet response during surgery in patients undergoing elective lower limb Department of orthopedics.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Select elective general anesthesia in 100 cases of lower extremity Department of orthopedics surgery patients were randomly divided into SGB group and control group, SGB group received anesthesia before the right stellate ganglion block intervention, the control group underwent right deltoid muscle injection, changes in hemodynamics in two groups were recorded in heart rate, blood pressure, and before anesthesia, after intubation 3min 1H, a tourniquet, tourniquet release before and after tourniquet release 3min, 30min, changes in blood physiological analysis.
The effect of stellate ganglion block on tourniquet response during perioperative period was observed.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tie Xu, MD
- Phone Number: 13952110889
- Email: xutie889@163.com
Study Contact Backup
- Name: Shuangshuang Meng, bachelor
- Phone Number: 15862167035
- Email: mengss@163.com
Study Locations
-
-
Jiangsu
-
Xuzhou, Jiangsu, China, 221000
- Recruiting
- The Affiliated Hospital of Xuzhou Medical University
-
Contact:
- Shuangshuang Meng, bachelor
- Phone Number: 15862167035
- Email: mengss@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- American Society of anesthesiologists Grade 1-3 Patients
- undergoing lower limb surgery under general anesthesia
- should be treated with tourniquet
Exclusion Criteria:
- Tourniquet application time is less than 1h, greater than 1.5h
- Abnormal coagulation function
- perioperative application of hormone
- lidocaine allergy
- can not cope with nerve block
- nerve block failure
- minimally invasive surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Stellate ganglion block
|
Stellate ganglion block with 1% lidocaine 10ml
|
Placebo Comparator: control group
Deltoid muscle injection
|
Deltoid muscle injection with 1% lidocaine 10ml
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
blood pressure
Time Frame: 2 hours in perioperative period
|
mmHg
|
2 hours in perioperative period
|
heart rate
Time Frame: 2 hours in perioperative period
|
bpm
|
2 hours in perioperative period
|
Lac
Time Frame: One minute after the radial artery puncture, the tourniquet was applied for 1 hours and the tourniquet was released 3 minutes after the tourniquet release 30 minutes
|
blood gas analysis mmol/L
|
One minute after the radial artery puncture, the tourniquet was applied for 1 hours and the tourniquet was released 3 minutes after the tourniquet release 30 minutes
|
cortisol
Time Frame: One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
ELISA ng/ml
|
One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
norepinephrine
Time Frame: One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
ELISA nmol/L
|
One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
Time Frame: One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
n nitrate reductase method μmol/L
|
One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
ET-1
Time Frame: One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
ELISA ng/L
|
One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
MDA
Time Frame: One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
ELISA nmol/ml
|
One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
SOD
Time Frame: One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
ELISA μg/L
|
One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
IL-6
Time Frame: One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
ELISA pg/ml
|
One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
cTn-T
Time Frame: One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
ELISA μg/L
|
One minute after the radial artery puncture, one minute after intubation, tourniquet application 1 hour, one minute before tourniquet, loose after a tourniquet for 3 minutes, 30 minutes after a tourniquet
|
postoperative pain
Time Frame: hour 1、hour 6、hour 24、hour 48 after operation
|
VAS score
|
hour 1、hour 6、hour 24、hour 48 after operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complication of puncture
Time Frame: 2 hours in perioperative period
|
bleeding、nerve injury、
|
2 hours in perioperative period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Tie Xu, MD, The Affiliated Hospital of Xuzhou Medical University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 2, 2017
Primary Completion (Anticipated)
June 30, 2018
Study Completion (Anticipated)
December 31, 2018
Study Registration Dates
First Submitted
June 1, 2017
First Submitted That Met QC Criteria
June 7, 2017
First Posted (Actual)
June 9, 2017
Study Record Updates
Last Update Posted (Actual)
June 9, 2017
Last Update Submitted That Met QC Criteria
June 7, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XYFY2017-KL012-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
IPD will be available when this trial is finished and the article have been published.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stellate Ganglion Block
-
Zhonghua Chen,MDShaoxing Hospital of Zhejiang UniversityActive, not recruitingPossible Molecular Mechanism of Left Stellate Ganglion Block | Left Stellate Ganglion Block Can Quickly Restore the Left Stellate GanglionChina
-
Zhonghua Chen,MDChina (Zhejiang) Health technology RESEARCH and development and transformation...RecruitingLeft Stellate Ganglion Block on Rapid Recovery | Possible Molecular Mechanism of Left Stellate Ganglion BlockChina
-
Eslam Ayman Mohamed ShawkiUnknownStellate Ganglion Block | Radial Artery CannulationEgypt
-
Rijnstate HospitalCompletedStellate Ganglion Block | Postmenopausal | Hot Flushes | Hot FlashNetherlands
-
Yangzhou UniversityCompleted
-
Mina sobhi said famRecruiting
-
Yangzhou UniversityRecruitingStellate Ganglion BlockChina
-
Yangzhou UniversityCompleted
-
Assiut UniversityUnknownIntubation | Stellate GanglionEgypt
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingPostoperative Nausea and Vomiting | Stellate Ganglion Block | Thyroid SurgeryChina
Clinical Trials on Stellate ganglion block
-
University of PennsylvaniaRecruitingVentricular TachycardiaUnited States
-
West Virginia UniversityCompletedCOVID-19 | Acute Respiratory Distress SyndromeUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
Institute for Clinical and Experimental MedicineRecruitingVentricular Fibrillation | Ventricular Tachycardia | Ventricular Arrythmia | Block | Arrhythmic StormCzechia
-
Tanta UniversityMohamad Gamal Elmawy, M.DRecruiting
-
Eslam Ayman Mohamed ShawkiUnknownStellate Ganglion Block | Radial Artery CannulationEgypt
-
Aswan UniversityRecruitingHemodialysis | Arteriovenous Fistula | Stellate Ganglion Block | Major Lower Limb Orthopedic SurgeryEgypt
-
Beijing Tiantan HospitalRecruitingAneurysmal Subarachnoid Hemorrhage | Stellate Ganglion Block | Cerebral VasospasmChina
-
VA Office of Research and DevelopmentAnalydata, IncRecruiting
-
Beijing Tiantan HospitalNot yet recruitingSubarachnoid Hemorrhage, Aneurysmal | Cerebral Vasospasm